vs
Side-by-side financial comparison of Acadia Healthcare Company, Inc. (ACHC) and WARRIOR MET COAL, INC. (HCC). Click either name above to swap in a different company.
Acadia Healthcare Company, Inc. is the larger business by last-quarter revenue ($829.0M vs $458.6M, roughly 1.8× WARRIOR MET COAL, INC.). WARRIOR MET COAL, INC. runs the higher net margin — 15.8% vs 0.5%, a 15.2% gap on every dollar of revenue. On growth, WARRIOR MET COAL, INC. posted the faster year-over-year revenue change (52.1% vs 7.5%). Over the past eight quarters, WARRIOR MET COAL, INC.'s revenue compounded faster (7.5% CAGR vs 2.0%).
Acadia Healthcare Company, Inc. is an American provider of for-profit behavioral healthcare services. It operates a network of over 225 facilities across the United States and Puerto Rico.
Warrior Met Coal, Inc. (ticker HCC) is a U.S.-headquartered mining enterprise that produces and distributes high-grade metallurgical coal, a key raw material for steel production. It serves steel manufacturers and industrial clients across core markets including North America, Europe, and Asia.
ACHC vs HCC — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $829.0M | $458.6M |
| Net Profit | $4.5M | $72.3M |
| Gross Margin | — | 36.7% |
| Operating Margin | — | 17.3% |
| Net Margin | 0.5% | 15.8% |
| Revenue YoY | 7.5% | 52.1% |
| Net Profit YoY | -50.8% | — |
| EPS (diluted) | $0.05 | $1.37 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $829.0M | $458.6M | ||
| Q4 25 | $821.5M | $384.0M | ||
| Q3 25 | $851.6M | $328.6M | ||
| Q2 25 | $869.2M | $297.5M | ||
| Q1 25 | $770.5M | $299.9M | ||
| Q4 24 | $774.2M | $297.5M | ||
| Q3 24 | $815.6M | $327.7M | ||
| Q2 24 | $796.0M | $396.5M |
| Q1 26 | $4.5M | $72.3M | ||
| Q4 25 | $-1.2B | $23.0M | ||
| Q3 25 | $36.2M | $36.6M | ||
| Q2 25 | $30.1M | $5.6M | ||
| Q1 25 | $8.4M | $-8.2M | ||
| Q4 24 | $32.6M | $1.1M | ||
| Q3 24 | $68.1M | $41.8M | ||
| Q2 24 | $78.5M | $70.7M |
| Q1 26 | — | 36.7% | ||
| Q4 25 | — | 29.5% | ||
| Q3 25 | — | 27.1% | ||
| Q2 25 | — | 23.9% | ||
| Q1 25 | — | 18.1% | ||
| Q4 24 | — | 23.1% | ||
| Q3 24 | — | 29.3% | ||
| Q2 24 | — | 34.1% |
| Q1 26 | — | 17.3% | ||
| Q4 25 | -142.4% | 9.0% | ||
| Q3 25 | 4.7% | 6.3% | ||
| Q2 25 | 5.8% | 2.6% | ||
| Q1 25 | 1.7% | -5.8% | ||
| Q4 24 | 4.9% | -1.4% | ||
| Q3 24 | 12.1% | 11.9% | ||
| Q2 24 | 13.4% | 17.9% |
| Q1 26 | 0.5% | 15.8% | ||
| Q4 25 | -143.3% | 6.0% | ||
| Q3 25 | 4.3% | 11.1% | ||
| Q2 25 | 3.5% | 1.9% | ||
| Q1 25 | 1.1% | -2.7% | ||
| Q4 24 | 4.2% | 0.4% | ||
| Q3 24 | 8.4% | 12.7% | ||
| Q2 24 | 9.9% | 17.8% |
| Q1 26 | $0.05 | $1.37 | ||
| Q4 25 | $-12.98 | $0.43 | ||
| Q3 25 | $0.40 | $0.70 | ||
| Q2 25 | $0.33 | $0.11 | ||
| Q1 25 | $0.09 | $-0.16 | ||
| Q4 24 | $0.36 | $0.02 | ||
| Q3 24 | $0.74 | $0.80 | ||
| Q2 24 | $0.85 | $1.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $158.5M | $233.2M |
| Total DebtLower is stronger | $2.5B | $154.4M |
| Stockholders' EquityBook value | $2.0B | — |
| Total Assets | $5.5B | $2.8B |
| Debt / EquityLower = less leverage | 1.29× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $158.5M | $233.2M | ||
| Q4 25 | $133.2M | $300.0M | ||
| Q3 25 | $118.7M | $336.3M | ||
| Q2 25 | $131.4M | $383.3M | ||
| Q1 25 | $91.2M | $454.9M | ||
| Q4 24 | $76.3M | $491.5M | ||
| Q3 24 | $82.1M | $583.2M | ||
| Q2 24 | $77.2M | $709.0M |
| Q1 26 | $2.5B | $154.4M | ||
| Q4 25 | $2.5B | $154.3M | ||
| Q3 25 | $2.3B | $154.1M | ||
| Q2 25 | $2.3B | $153.9M | ||
| Q1 25 | $2.2B | $153.8M | ||
| Q4 24 | $2.0B | $153.6M | ||
| Q3 24 | $1.9B | $153.5M | ||
| Q2 24 | $1.8B | $153.3M |
| Q1 26 | $2.0B | — | ||
| Q4 25 | $1.9B | $2.1B | ||
| Q3 25 | $3.1B | $2.1B | ||
| Q2 25 | $3.1B | $2.1B | ||
| Q1 25 | $3.0B | $2.1B | ||
| Q4 24 | $3.1B | $2.1B | ||
| Q3 24 | $3.0B | $2.1B | ||
| Q2 24 | $3.0B | $2.0B |
| Q1 26 | $5.5B | $2.8B | ||
| Q4 25 | $5.5B | $2.8B | ||
| Q3 25 | $6.4B | $2.7B | ||
| Q2 25 | $6.3B | $2.6B | ||
| Q1 25 | $6.1B | $2.6B | ||
| Q4 24 | $6.0B | $2.6B | ||
| Q3 24 | $5.9B | $2.6B | ||
| Q2 24 | $5.7B | $2.6B |
| Q1 26 | 1.29× | — | ||
| Q4 25 | 1.28× | 0.07× | ||
| Q3 25 | 0.74× | 0.07× | ||
| Q2 25 | 0.74× | 0.07× | ||
| Q1 25 | 0.72× | 0.07× | ||
| Q4 24 | 0.64× | 0.07× | ||
| Q3 24 | 0.62× | 0.07× | ||
| Q2 24 | 0.62× | 0.07× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $61.5M | — |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | 13.78× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $61.5M | — | ||
| Q4 25 | $-86.3M | $76.1M | ||
| Q3 25 | $73.2M | $104.7M | ||
| Q2 25 | $133.5M | $37.5M | ||
| Q1 25 | $11.5M | $10.9M | ||
| Q4 24 | $116.7M | $54.2M | ||
| Q3 24 | $163.1M | $62.2M | ||
| Q2 24 | $171.1M | $147.0M |
| Q1 26 | — | — | ||
| Q4 25 | $-179.5M | — | ||
| Q3 25 | $-63.0M | — | ||
| Q2 25 | $-34.2M | — | ||
| Q1 25 | $-163.2M | — | ||
| Q4 24 | $-86.8M | — | ||
| Q3 24 | $-27.1M | — | ||
| Q2 24 | $16.9M | — |
| Q1 26 | — | — | ||
| Q4 25 | -21.8% | — | ||
| Q3 25 | -7.4% | — | ||
| Q2 25 | -3.9% | — | ||
| Q1 25 | -21.2% | — | ||
| Q4 24 | -11.2% | — | ||
| Q3 24 | -3.3% | — | ||
| Q2 24 | 2.1% | — |
| Q1 26 | — | — | ||
| Q4 25 | 11.3% | — | ||
| Q3 25 | 16.0% | — | ||
| Q2 25 | 19.3% | — | ||
| Q1 25 | 22.7% | — | ||
| Q4 24 | 26.3% | — | ||
| Q3 24 | 23.3% | — | ||
| Q2 24 | 19.4% | — |
| Q1 26 | 13.78× | — | ||
| Q4 25 | — | 3.31× | ||
| Q3 25 | 2.02× | 2.86× | ||
| Q2 25 | 4.43× | 6.70× | ||
| Q1 25 | 1.37× | — | ||
| Q4 24 | 3.58× | 47.68× | ||
| Q3 24 | 2.39× | 1.49× | ||
| Q2 24 | 2.18× | 2.08× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACHC
| Acute Inpatient Psychiatric Facilities | $471.0M | 57% |
| Other | $140.0M | 17% |
| Specialty Treatment Facilities | $128.0M | 15% |
| Residential Treatment Facilities | $90.0M | 11% |
HCC
| Sales | $448.5M | 98% |
| Other revenues | $10.1M | 2% |
